News – Page 1151 – Endpoints News

TiGenix’s second stab at an IPO bags $36M for late-stage stem cell plans

9 years ago

Can the new CEO at Genentech maintain a tradition of groundbreaking R&D?

9 years ago

Lonza bags Capsugel and its oral drug delivery tech for $5.5B: Biotech vet Truex named COO at Synlogic

9 years ago

Xtandi fails a combo study, blocking a path to continued use for Pfizer, Astellas

9 years ago

Flagship takes on a pioneering new fund — and name — adding $285M to advance its startup mission

9 years ago

Pfizer racks up an FDA approval for eczema blockbuster hopeful crisaborole

9 years ago

New drug OKs fell off a cliff in 2016 and the FDA wants you to know why

9 years ago

INC Research promises 550 new jobs as it plots headquarters move

9 years ago

Analysts track a payer revolt against Sarepta’s controversial Duchenne drug

9 years ago

Pfizer inks an early-stage collaboration deal as it invests in another startup; Stem cell startup lands cardiac tech

9 years ago

Armed with $55M in Third Rock cash, Goldfinch Bio sets out to build a kidney disease pipeline

9 years ago

Stiff-armed by a stubborn Actelion, J&J takes its check book and walks away, leaving an opening for Sanofi

9 years ago

It’s the law: Obama signs widely popular 21st Century Cures Act

9 years ago

Bristol-Myers outlines a big R&D overhaul covering East, West Coast operations

9 years ago

Scott Gottlieb takes a turn in the spotlight for FDA candidates; Triumphant Achaogen lines up stock sale

9 years ago

Kyowa Hakko Kirin hit with a new PhIII setback on an old Parkinson’s drug

9 years ago

GSK preps for vaccine R&D expansion, 200 hires for new global hub

9 years ago

Proteon triggers a stock implosion as its first PhIII proves to be a bust

9 years ago

Learning from past mistakes, Centrexion clears a big PhIIb hurdle for its pain drug

9 years ago

Big Pharma’s woeful numbers on drug R&D just got even worse

9 years ago

New York gambles $1.15B in new funds and incentives in search of a biotech jackpot

9 years ago

Pfizer bankrolls an oncolytics biotech upstart with an eye on a future buyout

9 years ago

Maris pulls the plug on biotech fund, goes back on hiatus; Flexion files and Sanofi brings out the ax

9 years ago

As FDA assesses its antibiotic, Cempra bids longtime CEO Prabha Fernandes goodbye

9 years ago

First page Previous page 1148 1149 115011511152 1153 1154 Next page Last page